Holy #LanguageMatters. I wish I could teleport @RenzaS to where I am. There’s so many poor language choices and stigma happening that I don’t even know where to start as an audience member to this presentation.
😑🙈🙉🙊
Realizing that next week marks *17* years of living with type 1 diabetes and so much has changed but at the same time, nothing has. The stigma I am hearing today in this room as a person with diabetes is exactly how I felt when diagnosed in 2002.
I am upset about it to the point of tears and I have to address it in my own presentation in a few hours. I may actually tear up on stage, which I’ve never done before, because it’s so frustrating.
Wrote email to conf organizer (there’s no breaks in sessions before my talk) & got best possible response back (Roughly: thanking for feedback, asking what they can do to help, offering to talk more). 👍🏻 that’s helping, although I still plan to address the audience about it.
Ducked out & chatted in person w/ conf organizer to tell them I’d be addressing issue of language and stigma at start of my talk, tying it to my own experiences as well. They are very supportive of my plan. Teared up talking to them so likely will also get choked up on stage.
Both in email and in person, conf organizer was amazingly receptive to the real-time feedback and talking through the issues. It really, really helps to have people who are supportive in situations like this, because it’s very hard to challenge a room full of HCPs as a patient.
Phew. Gave talk, modified w/ intro to address stigma & how we treat people with diabetes in HC and in society and how we need to do better. Then segued back to the usual. Did not cry on stage but it was close. Not sure how effective it was but glad I used the stage to speak up.👍🏻
Thanks everyone for the digital/virtual encouragement today. That, too, helps fuel advocacy. 💜🙏🏼
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/ What if there was a tool to help identify who might have exocrine pancreatic insufficiency (EPI/PEI)?
EPI is a significant issue for many people with diabetes (likely more common than gastroparesis or celiac).
Here's how such a tool can help PWD👇🏼🧵
#ADASciSessions #ADA2024
2/ The Exocrine Pancreatic Insufficiency Symptom Score (EPI/PEI-SS) has 15 symptoms, rated by how frequent they are and how bothersome they are (aka severity).
n=324 ppl participated in a real-world survey.
n=118 were people with diabetes (PWD)!
#ADASciSessions #ADA2024
3/ Methods:
EPI/PEI-SS scores were analyzed and compared between PWD (n=118), with EPI (T1D: n=14; T2D: n=20) or without EPI (T1D: n=78; T2D: n=6), and people without diabetes (n=206) with and without EPI.
📣 Presentation of the primary outcome results from the CREATE Trial, which assessed open source automated insulin delivery (AID) compared to sensor-augmented pump therapy (SAPT) in adults & kids with T1D, at #ADA2022!
The CREATE trial aimed to study the efficacy and safety of an open source automated insulin delivery system, with a large scale, long term randomized controlled trial.
I just realized it's been 3 (!) years since I published my book on automated insulin delivery, with the goal of helping increased conversation and understanding of AID technology for people with diabetes, their loved ones, and healthcare providers!
I'm still very proud that it is available to read for free online, free to download a PDF (both of which have been done thousands of times each: ArtificialPancreasBook.com), or as an e-book, paperback, and now hardback copy. Proceeds from the purchased copies go to Life For A Child.
And, more recently, it has also been translated into French by the wonderful Dr. Mihaela Muresan and Olivier Legendre!
The French translation is available in Kindle, paperback, hardback, or free PDF download formats as well.
1/THREAD - my presentation is kicking off at #EASD2020 about open source automated insulin delivery.
(You can see a full version of my presentation here: bit.ly/DanaMLewisEASD…, or read the summary below!)
Note we should differentiate between open source (where the source of something is open), and DIY (do-it-yourself) implementations of open source code. Open source means it can be reviewed and used by individuals (thus, DIY or #DIYAPS) or by companies.
Poster 988-P at #ADA2020 by Jennifer Zabinsky, Haley Howell, Alireza Ghezavati, @DanaMLewis Andrew Nguyen, and Jenise Wong: “Do-It-Yourself Artificial Pancreas Systems Reduce Hyperglycemia Without Increasing Hypoglycemia”
This was a retrospective double cohort study that evaluated data from the @OpenAPS Data Commons (data ranged from 2017-2019) and compared it to conventional sensor-augmented pump (SAP) therapy from the @Tidepool_org Big Data Donation Project. #ADA2020
One month of CGM data (with more than 70% of the month spent using CGM), as long as they were >1 year of living with T1D, was used from the @OpenAPS Data Commons. People could be using any type of DIYAPS (OpenAPS, Loop, or AndroidAPS) and there were no age restrictions. #ADA2020
Poster 99-LB at #ADA2020 by @danamlewis, @azure_dominique, and Lance Kriegsfeld, “Multi-Timescale Interactions of Glucose and Insulin in Type 1 Diabetes Reveal Benefits of Hybrid Closed Loop Systems“
Background - Blood glucose and insulin exhibit coupled biological rhythms at multiple timescales, including hours (ultradian, UR) and the day (circadian, CR) in individuals without diabetes. But, biological rhythms in longitudinal data have not been mapped in T1D. #ADA2020
It is not known exactly how glucose and insulin rhythms compare between T1D and non-T1D, and whether rhythms are affected by type of therapy (Sensor Augmented Pump (SAP) or Hybrid Closed Loop (HCL)). #ADA2020